Newport Kelda, Bishop Lisa, Donnan Jennifer, Pal Shefali, Najafizada Maisam
School of Pharmacy, Memorial University of Newfoundland and Labrador, St. John's, NL, A1B 3V6, Canada.
Faculty of Medicine, Memorial University of Newfoundland and Labrador, 300 Prince Phillip Drive, NL, A1B 3V6, St. John's, Canada.
J Cannabis Res. 2023 Jul 31;5(1):31. doi: 10.1186/s42238-023-00196-7.
Since the start of the COVID-19 pandemic in Canada, the cannabis industry has adapted to public health emergency orders which had direct and indirect consequences on cannabis consumption. The objective of this scoping review was to describe the patterns of consumption and cannabis-related health and safety considerations during the COVID-19 pandemic in Canada.
For this scoping review, we searched four electronic databases supplemented with grey literature. Peer-reviewed or pre-print studies using any study design and grey literature reporting real-world data were included if published in English between March 2020 and September 2021 and focused on cannabis and COVID-19 in Canada. A content analysis was performed.
Twenty-one studies met the inclusion/exclusion criteria. Study designs included cross-sectional surveys (n = 17), ecological study (n = 1), conceptual paper (n = 1), longitudinal study (n = 1), and prospective cohort study (n = 1). Most were conducted solely in Canada (n = 18), and the remaining included global data. Our content analysis suggested that cannabis consumption during the pandemic varied by reasons for use, consumers' age, gender, and method of consumption. Health and safety impacts due to the COVID-19 pandemics included increased mental illness, increased emergency visits, and psychosocial impacts.
This scoping review suggested that the impact of the pandemic on cannabis consumption in Canada is more complex than simplistic assumptions of an increase or decrease in consumption and continues to be difficult to measure. This study has explored some of those complexities in relation to reasons for use, age, gender, method of consumption, and health impacts. This scoping review is limited by focusing on the breadth compared to depth.
Legalizing nonmedical use of cannabis in Canada in 2018 has had its challenges of implementation, one of which has been the changing context of the society. The findings of this study can help inform cannabis policy updates in Canada as the country is reaching its fifth year of legalizing nonmedical use of cannabis.
自加拿大新冠疫情开始以来,大麻产业已适应公共卫生紧急命令,这些命令对大麻消费产生了直接和间接影响。本范围综述的目的是描述加拿大新冠疫情期间的消费模式以及与大麻相关的健康和安全考量因素。
对于本范围综述,我们检索了四个电子数据库,并辅以灰色文献。如果研究在2020年3月至2021年9月期间以英文发表,采用任何研究设计的同行评审或预印本研究以及报告真实世界数据的灰色文献,且聚焦于加拿大的大麻和新冠疫情,则纳入研究。进行了内容分析。
21项研究符合纳入/排除标准。研究设计包括横断面调查(n = 17)、生态学研究(n = 1)、概念性论文(n = 1)、纵向研究(n = 1)和前瞻性队列研究(n = 1)。大多数研究仅在加拿大进行(n = 18),其余研究包括全球数据。我们的内容分析表明,疫情期间大麻消费因使用原因、消费者年龄、性别和消费方式而异。新冠疫情造成的健康和安全影响包括精神疾病增加、急诊就诊增加以及社会心理影响。
本范围综述表明,疫情对加拿大大麻消费的影响比消费增加或减少的简单假设更为复杂,且仍然难以衡量。本研究探讨了与使用原因、年龄、性别、消费方式和健康影响相关的一些复杂性。与深度相比,本范围综述侧重于广度,存在局限性。
2018年加拿大将非医用大麻合法化面临实施挑战,其中之一是社会环境不断变化。随着加拿大进入非医用大麻合法化的第五年,本研究结果可为加拿大的大麻政策更新提供参考。